{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"82.46","upperLimit":"98.66","value":"93.62"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"47"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"description":"All regimens were analyzed together.","id":"OG000","title":"All Participants"}],"paramType":"NUMBER","populationDescription":"All participants","reportingStatus":"POSTED","timeFrame":"Within 6 months after PBSCT","title":"Safety, as Defined by Serious Adverse Events and Adverse Events Related to Study Treatment.","type":"PRIMARY","unitOfMeasure":"% of participants with a reported SAE"}